nivolumab nell’arcc: oltre l’efficacia
Published 5 years ago • 239 plays • Length 3:40Download video MP4
Download video MP3
Similar videos
-
2:45
nivolumab nell’arcc: efficacia nella malattia aggressiva
-
5:52
nivolumab and salvage nivolumab plus ipilimumab for arcc
-
6:16
treatment-free survival results of nivolumab and salvage nivolumab ipilimumab for accrcc
-
0:37
dr. petrylak on fda approval of nivolumab in bladder cancer
-
2:05
chemo-immunotherapy combo nivolumab and nab-paclitaxel could be effective perioperative strategy...
-
0:39
dr. atkinson on when to use nivolumab monotherapy versus nivolumab/ipilimumab combination
-
6:14
neoadjuvant ipilimumab plus nivolumab improves outcomes in resectable advanced melanoma
-
2:41
checkmate 9er: glycoproteomic biomarkers for nivolumab and cabozantinib in arcc
-
2:27
study finds neoadjuvant nivolumab to show long-term benefit in patients with nsclc
-
1:01
dr. heymach on nivolumab for lung cancer
-
1:00
prime-hcc: ipilimumab and nivolumab in liver cancer
-
1:55
fda approves opdivo® (nivolumab) in the united states
-
2:01
dr. reardon on nivolumab/ipilimumab in glioblastoma
-
0:46
dr. herbst on nivolumab for nsclc
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
1:01
dr. renato martins on the unprecedented effects of nivolumab and ipilimumab
-
1:00
dr. ferris on pembrolizumab and nivolumab in head and neck cancer
-
7:36
mrcc patient selection for ipilimumab/nivolumab